At one time all gliomas of the brainstem were thought to
have an equally poor outcome. Over the
years (especially with better imaging), we have come to find not all brainstem
gliomas are the same.— and actually some
brainstem gliomas (tectal gliomas, cervicomedullary gliomas, focal gliomas)
were found to have a favorable prognosis.
However, the vast majority of brainstem gliomas- perhaps 85%- were
diffuse and intrinsic and pontine.
These DIPGs, diffuse intrinsic pontine gliomas were all though to the
same terrible life expectancy.
Now it has been found that not all DIPGs are the same. Some children initially diagnosed with
diffuse intrinsic pontine gliomas unexpectedly had prolonged survival. There seems to be increasing understanding
that some of these tumors are typical with the predicted short survival; then
there are others that are atypical and might have longer time.
So what makes a DIPG atypical versus typical?
Typical Imaging-
1)
The tumor is diffuse without exophytic
components or focality, The tumor is
mixed in through normal tissue like “sand in grass” or “pepper in jello”.
2)
The epicenter is located in the pons.
3)
A majority of the base of the pons is affected. Some
trials require 50% while others require infiltration of 2/3 of the basis pons.
Typical Clinical Features-
1)
Age- So far seems to be written as more than 3
years of age to 18 or 21. Younger and
older patients with diffuse intrinsic pontine tumors are more likely to have
prolonged survival.
2)
Clinical Symptoms Triad- Children at the time of
presentation tend to have 2 out of 3 typical symptoms. The typical triad includes a) ataxia/unbalanced
gait, b) cranial nerve signs, and c) “long tract signs”- often weakness on one
side.
3)
Symptom progression-Symptoms progress rapidly
within one to two months from onset to diagnosis.
So, what difference does typical versus atypical make?
Those with atypical radiographic appearance or clinical features a may have increased survival. This may be because these tumors are not
high grade gliomas. Thus, many DIPG trials
are requiring biopsy for those children that are atypical. If one is atypical a difference treatment
course might be recommended.
It is likely better to know if a child is atypical before
choosing a treatment course. To get
another opinion one can contact the DIPG Registry (http://dipgregistry.org/patients-families/second-opinion/)
or potentially contact a primary investigator of a DIPG trial ( www.clinicaltrials.gov).
or potentially contact a primary investigator of a DIPG trial (
Note: As we gain more
understanding of diffuse intrinsic pontine tumors the categorization and
definitions will probably change just as we have seen over the last couple
decades.